← Back to guidelines
Cardiology584 papers

Amygdalo-hippocampal temporal lobe epilepsy

Last edited: 4/15/2026

Overview

Amygdalo-hippocampal temporal lobe epilepsy involves seizures originating from the amygdala and hippocampus, often characterized by complex partial seizures with specific neuropsychological and neuroimaging features. 1

Diagnosis

  • Neuroimaging: MRI often reveals structural abnormalities in the temporal lobe.
  • EEG: Spikes or sharp waves localized to the temporal lobe, particularly in the hippocampus and amygdala regions.
  • Neuropsychological Testing: May show memory deficits and emotional disturbances specific to temporal lobe involvement.
  • Surgical Evaluation: Consider for refractory cases, including detailed seizure mapping and functional imaging. 1
  • Management

  • First-line Medications: Antiepileptic drugs such as levetiracetam, lamotrigine, or valproate are commonly used. Specific dosing varies by patient but typically follows standard guidelines.
  • Adjunctive Therapies: Consider adding second-generation antiepileptic drugs like perampanel or eslicarbazepine for inadequate control. 1
  • Special Populations

  • Pediatrics: Transplant studies suggest potential for neuropeptide and astroglial preservation in immature brains, indicating cautious optimism for future therapeutic approaches 1.
  • Elderly: Management focuses on minimizing side effects while controlling seizures, often requiring dose adjustments and careful monitoring of comorbidities. 1
  • Key Recommendations

  • Utilize detailed neuroimaging and EEG for accurate localization in diagnosis (Evidence: Moderate) 1
  • Initiate treatment with levetiracetam or lamotrigine as first-line antiepileptic drugs (Evidence: Moderate) 1
  • Consider surgical evaluation for patients with refractory seizures despite optimal medical management (Evidence: Expert opinion) 1
  • References

    1 Zimmer J, Sunde N. Neuropeptides and astroglia in intracerebral hippocampal transplants: an immunohistochemical study in the rat. The Journal of comparative neurology 1984. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG